Which has better valuation and earnings, ICU or ZYXI?

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SeaStar Medical $1.23M 10.67 -$12.15M -$4.80 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is ICU or ZYXI more profitable?

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets SeaStar Medical -828.62% -146.29% -96.48% Zynex -68.35% -804.30% -36.67%

Which has preferable valuation and earnings, SURG or ZYXI?

Zynex has higher revenue and earnings than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SurgePays $56.96M 0.23 -$36.07M -$1.94 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is SURG or ZYXI more profitable?

SurgePays has a net margin of -64.91% compared to Zynex's net margin of -68.35%. Zynex's return on equity of -804.30% beat SurgePays' return on equity. Company Net Margins Return on Equity Return on Assets SurgePays -64.91% -967.32% -310.16% Zynex -68.35% -804.30% -36.67%

Do analysts rate ZYXI or MBAI?

Zynex currently has a consensus price target of $4.90, indicating a potential upside of 3,820.00%. Given Zynex's stronger consensus rating and higher possible upside, research analysts plainly believe Zynex is more favorable than Check-Cap. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ZYXI or MBAI more profitable?

Check-Cap has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Check-Cap's return on equity of 0.00% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Check-Cap N/A N/A N/A

Which has higher earnings and valuation, ZYXI or LFWD?

Zynex has higher revenue and earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A Lifeward $22.03M 0.93 -$19.91M -$19.66 N/A

Is ZYXI or LFWD more profitable?

Zynex has a net margin of -68.35% compared to Lifeward's net margin of -123.66%. Lifeward's return on equity of -243.14% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Lifeward -123.66% -243.14% -97.39%

Zynex (ZYXI) Competitors

$0.12 0.00 (0.00%)

As of 06/2/2026

Compare

ZYXI vs. ICU, SURG, MBAI, ALUR, and LFWD

Should you buy Zynex stock or one of its competitors? MarketBeat compares Zynex with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zynex include SeaStar Medical (ICU), SurgePays (SURG), Check-Cap (MBAI), Allurion Technologies (ALUR), and Lifeward (LFWD). These companies are all part of the "medical equipment" industry.

How does Zynex compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	10.67	-$12.15M	-$4.80	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 49.3% of Zynex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SeaStar Medical presently has a consensus price target of $8.00, indicating a potential upside of 143.90%. Zynex has a consensus price target of $4.90, indicating a potential upside of 3,820.00%. Given Zynex's higher probable upside, analysts clearly believe Zynex is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zynex	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, SeaStar Medical had 1 more articles in the media than Zynex. MarketBeat recorded 1 mentions for SeaStar Medical and 0 mentions for Zynex. SeaStar Medical's average media sentiment score of 1.89 beat Zynex's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the media.

Company	Overall Sentiment
SeaStar Medical	Very Positive
Zynex	Neutral

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-828.62%	-146.29%	-96.48%
Zynex	-68.35%	-804.30%	-36.67%

SeaStar Medical has a beta of -1.05, meaning that its stock price is 205% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Summary

Zynex beats SeaStar Medical on 10 of the 14 factors compared between the two stocks.

How does Zynex compare to SurgePays?

SurgePays (NASDAQ:SURG) and Zynex (NASDAQ:ZYXI) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

SurgePays has a net margin of -64.91% compared to Zynex's net margin of -68.35%. Zynex's return on equity of -804.30% beat SurgePays' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SurgePays	-64.91%	-967.32%	-310.16%
Zynex	-68.35%	-804.30%	-36.67%

Zynex has higher revenue and earnings than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SurgePays	$56.96M	0.23	-$36.07M	-$1.94	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

SurgePays has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

In the previous week, SurgePays had 2 more articles in the media than Zynex. MarketBeat recorded 2 mentions for SurgePays and 0 mentions for Zynex. SurgePays' average media sentiment score of 0.77 beat Zynex's score of 0.00 indicating that SurgePays is being referred to more favorably in the media.

Company	Overall Sentiment
SurgePays	Positive
Zynex	Neutral

6.9% of SurgePays shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 29.1% of SurgePays shares are owned by insiders. Comparatively, 49.3% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SurgePays currently has a consensus target price of $5.00, indicating a potential upside of 851.29%. Zynex has a consensus target price of $4.90, indicating a potential upside of 3,820.00%. Given Zynex's stronger consensus rating and higher possible upside, analysts clearly believe Zynex is more favorable than SurgePays.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SurgePays	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Zynex	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Zynex beats SurgePays on 10 of the 15 factors compared between the two stocks.

How does Zynex compare to Check-Cap?

Zynex (NASDAQ:ZYXI) and Check-Cap (NASDAQ:MBAI) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

Check-Cap has lower revenue, but higher earnings than Zynex. Check-Cap is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Check-Cap	N/A	N/A	$4.14M	-$2.77	N/A

Zynex currently has a consensus price target of $4.90, indicating a potential upside of 3,820.00%. Given Zynex's stronger consensus rating and higher possible upside, research analysts plainly believe Zynex is more favorable than Check-Cap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Check-Cap had 2 more articles in the media than Zynex. MarketBeat recorded 2 mentions for Check-Cap and 0 mentions for Zynex. Check-Cap's average media sentiment score of 0.94 beat Zynex's score of 0.00 indicating that Check-Cap is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
Check-Cap	Positive

Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, Check-Cap has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

Check-Cap has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Check-Cap's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Check-Cap	N/A	N/A	N/A

29.7% of Zynex shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 49.3% of Zynex shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Zynex beats Check-Cap on 9 of the 15 factors compared between the two stocks.

How does Zynex compare to Allurion Technologies?

Allurion Technologies (NYSE:ALUR) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

In the previous week, Allurion Technologies had 1 more articles in the media than Zynex. MarketBeat recorded 1 mentions for Allurion Technologies and 0 mentions for Zynex. Allurion Technologies' average media sentiment score of 1.42 beat Zynex's score of 0.00 indicating that Allurion Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Allurion Technologies	Positive
Zynex	Neutral

21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 8.1% of Allurion Technologies shares are held by insiders. Comparatively, 49.3% of Zynex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Zynex has a net margin of -68.35% compared to Allurion Technologies' net margin of -199.96%. Allurion Technologies' return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allurion Technologies	-199.96%	N/A	-77.13%
Zynex	-68.35%	-804.30%	-36.67%

Zynex has higher revenue and earnings than Allurion Technologies. Allurion Technologies is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allurion Technologies	$17.21M	0.74	-$7.20M	-$1.75	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

Allurion Technologies currently has a consensus target price of $3.00, suggesting a potential upside of 250.88%. Zynex has a consensus target price of $4.90, suggesting a potential upside of 3,820.00%. Given Zynex's higher possible upside, analysts plainly believe Zynex is more favorable than Allurion Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allurion Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zynex	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Allurion Technologies has a beta of -0.18, indicating that its stock price is 118% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Summary

Zynex beats Allurion Technologies on 9 of the 14 factors compared between the two stocks.

How does Zynex compare to Lifeward?

Zynex (NASDAQ:ZYXI) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Zynex has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market.

In the previous week, Lifeward had 6 more articles in the media than Zynex. MarketBeat recorded 6 mentions for Lifeward and 0 mentions for Zynex. Lifeward's average media sentiment score of 1.47 beat Zynex's score of 0.00 indicating that Lifeward is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
Lifeward	Positive

Zynex currently has a consensus price target of $4.90, indicating a potential upside of 3,820.00%. Lifeward has a consensus price target of $10.00, indicating a potential upside of 37.36%. Given Zynex's higher possible upside, analysts clearly believe Zynex is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lifeward	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Zynex has higher revenue and earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Lifeward	$22.03M	0.93	-$19.91M	-$19.66	N/A

Zynex has a net margin of -68.35% compared to Lifeward's net margin of -123.66%. Lifeward's return on equity of -243.14% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Lifeward	-123.66%	-243.14%	-97.39%

29.7% of Zynex shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 49.3% of Zynex shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Zynex beats Lifeward on 10 of the 14 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZYXI vs. The Competition

Export

Metric	Zynex	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.80M	$8.16B	$6.47B	$12.54B
Dividend Yield	N/A	2.61%	2.69%	5.22%
P/E Ratio	-0.05	15.39	22.39	24.18
Price / Sales	0.04	7.06	520.79	112.26
Price / Cash	0.51	17.10	41.34	57.13
Price / Book	0.11	3.53	9.84	6.72
Net Income	$2.99M	$224.05M	$3.57B	$337.19M
7 Day Performance	N/A	-1.09%	-1.16%	0.48%
1 Month Performance	N/A	0.34%	3.85%	5.07%
1 Year Performance	-94.16%	-0.29%	27.40%	34.25%

Zynex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZYXI Zynex	N/A	$0.13 flat	$4.90 +3,820.0%	N/A	$3.80M	$108.20M	N/A	770
ICU SeaStar Medical	3.0199 of 5 stars	$3.52 -6.1%	$8.00 +127.3%	-70.1%	$14.08M	$1.23M	N/A	2
SURG SurgePays	3.0793 of 5 stars	$0.51 +2.2%	$5.00 +874.7%	-81.3%	$12.89M	$56.96M	N/A	40	Short Interest Decrease
MBAI Check-Cap	0.2751 of 5 stars	$1.73 -2.8%	N/A	N/A	$12.61M	N/A	N/A	80	Gap Down
ALUR Allurion Technologies	1.954 of 5 stars	$0.80 -3.5%	$3.00 +275.0%	-73.5%	$12.00M	$17.21M	N/A	501	News Coverage Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZYXI) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zynex (ZYXI) Competitors

ZYXI vs. ICU, SURG, MBAI, ALUR, and LFWD

How does Zynex compare to SeaStar Medical?

Summary

How does Zynex compare to SurgePays?

Summary

How does Zynex compare to Check-Cap?

Summary

How does Zynex compare to Allurion Technologies?

Summary

How does Zynex compare to Lifeward?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zynex (ZYXI) Competitors

ZYXI vs. ICU, SURG, MBAI, ALUR, and LFWD

How does Zynex compare to SeaStar Medical?

Which has better valuation and earnings, ICU or ZYXI?

Do institutionals and insiders believe in ICU or ZYXI?

Do analysts rate ICU or ZYXI?

Does the media prefer ICU or ZYXI?

Is ICU or ZYXI more profitable?

Which has more risk & volatility, ICU or ZYXI?

Summary

How does Zynex compare to SurgePays?

Is SURG or ZYXI more profitable?

Which has preferable valuation and earnings, SURG or ZYXI?

Which has more volatility and risk, SURG or ZYXI?

Does the media favor SURG or ZYXI?

Do insiders and institutionals believe in SURG or ZYXI?

Do analysts prefer SURG or ZYXI?

Summary

How does Zynex compare to Check-Cap?

Which has better earnings and valuation, ZYXI or MBAI?

Do analysts rate ZYXI or MBAI?

Does the media refer more to ZYXI or MBAI?

Which has more volatility and risk, ZYXI or MBAI?

Is ZYXI or MBAI more profitable?

Do institutionals & insiders have more ownership in ZYXI or MBAI?

Summary

How does Zynex compare to Allurion Technologies?

Does the media prefer ALUR or ZYXI?

Do insiders & institutionals hold more shares of ALUR or ZYXI?

Is ALUR or ZYXI more profitable?

Which has higher valuation and earnings, ALUR or ZYXI?

Do analysts prefer ALUR or ZYXI?

Which has more volatility & risk, ALUR or ZYXI?

Summary

How does Zynex compare to Lifeward?

Which has more risk & volatility, ZYXI or LFWD?

Does the media refer more to ZYXI or LFWD?

Do analysts prefer ZYXI or LFWD?

Which has higher earnings and valuation, ZYXI or LFWD?

Is ZYXI or LFWD more profitable?

Do institutionals & insiders believe in ZYXI or LFWD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools